Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Operating Leases (2018 - 2026)

Profound Medical has reported Operating Leases over the past 8 years, most recently at $72000.0 for Q2 2025.

  • For Q2 2025, Operating Leases fell 79.72% year-over-year to $72000.0; the TTM value through Jun 2025 reached $72000.0, down 79.72%, while the annual FY2024 figure was $203000.0, 59.72% down from the prior year.
  • Operating Leases for Q2 2025 was $72000.0 at Profound Medical, down from $136000.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $1.1 billion in Q1 2022 and troughed at $72000.0 in Q2 2025.
  • A 5-year average of $108.8 million and a median of $708000.0 in 2023 define the central range for Operating Leases.
  • Biggest five-year swings in Operating Leases: skyrocketed 131511.32% in 2021 and later crashed 99.94% in 2024.
  • Year by year, Operating Leases stood at $1.4 million in 2021, then plummeted by 40.67% to $817000.0 in 2022, then tumbled by 38.31% to $504000.0 in 2023, then tumbled by 59.72% to $203000.0 in 2024, then crashed by 64.53% to $72000.0 in 2025.
  • Business Quant data shows Operating Leases for PROF at $72000.0 in Q2 2025, $136000.0 in Q1 2025, and $203000.0 in Q4 2024.